MedTrace Logo

The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms

NCT06607523 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2025-12-19

No results posted yet for this study

Summary

The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.

Conditions

  • Brain Injuries

Interventions

DIETARY_SUPPLEMENT

Inulin

Inulin, 4g twice daily for 42 days

Sponsors & Collaborators

  • Moody Neurorehabilitation Institute

    collaborator UNKNOWN

  • The University of Texas Medical Branch, Galveston

    lead OTHER

Principal Investigators

  • Randall Urban, MD · University of Texas

  • Ana Durand, MD · Moody Neurorehabilitation Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-06
Primary Completion
2028-10-01
Completion
2028-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06607523 on ClinicalTrials.gov